Novo Nordisk A/S
XBER:NOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
XBER:NOVA
|
DK |
|
A
|
Avalon Technologies Ltd
NSE:AVALON
|
IN |
|
Jfrog Ltd
NASDAQ:FROG
|
US |
|
A
|
Ameresco Inc
F:4AM
|
US |
|
Norbit ASA
OSE:NORBT
|
NO |
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVA's stock price target?
Not Available
NOVA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
-3%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 8 years is -1%.
